Preoperative β‐cell function in patients with type 2 diabetes is important for the outcome of Roux‐en‐Y gastric bypass surgery
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Key points: Roux‐en‐Y gastric bypass surgery leads to remission of type 2 diabetes in the majority of patients suffering from the disease. The gut hormone glucagon‐like peptide‐1 is believed to be of major importance for the remission process. The present project demonstrates a marked difference in the chance of remission of type 2 diabetes in patients with low or high preoperative β‐cell function in spite of a similar post‐surgery increase in postprandial glucagon‐like peptide‐1 release. Furthermore, post‐surgery intravenous glucose administration, which does not stimulate release of glucagon‐like peptide‐1, leads to increased insulin secretion in the patients with the best preoperative β‐cell function. Together the present findings indicate that patients with type 2 diabetes with high preoperative β‐cell function experience a glucagon‐like peptide‐1‐independent increase in β‐cell function after gastric bypass surgery. The majority of the patients with type 2 diabetes (T2DM) show remission after Roux‐en‐Y gastric bypass (RYGB). This is the result of increased postoperative insulin sensitivity and β‐cell secretion. The aim of the present study was to elucidate the importance of the preoperative β‐cell function in T2DM for the chance of remission after RYGB. Fifteen patients with and 18 without T2DM had 25 g oral (OGTT) and intravenous (IVGTT) glucose tolerance tests performed at inclusion, after a diet‐induced weight loss, and 4 and 18 months after RYGB. Postoperative first phase insulin secretion rate (ISR) during the IVGTT and β‐cell glucose sensitivity during the OGTT increased in T2DM. Postoperative insulin sensitivity and the disposition index (DI) markedly increased in both groups. By stratifying the T2DM into two groups according to highest (T2DM high) and lowest (T2DM low) baseline DI, a restoration of first phase ISR and β‐cell glucose sensitivity were seen only in T2DM high. Remission of type 2 diabetes was 71 and 38% in T2DM high and T2DM low, respectively. Postoperative postprandial GLP‐1 concentrations increased markedly, but did not differ between the groups. Our findings emphasize the importance of the preoperative of β‐cell function for remission of diabetes after RYGB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“The procedure results in loss of 60% of excess weight (Buchwald et al. 2009), and the majority of the patients with type 2 diabetes experience a rapid improvement in glycaemic control, often leading to long lasting remission of the disease (Sjostrom, 2013).”
BackgroundBariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901 · cited 1×
“This makes RYGB superior to the current optimal medical treatment for diabetes (Mingrone et al. 2012; Schauer et al. 2012, 2014).”
BackgroundSjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741
Laferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682 · cited 2×
“…but in addition a major increase in postprandial glucagon-like peptide-1 (GLP-1) plasma concentration is a constant finding after RYGB (le Roux et al. 2007; Laferrere et al. 2007, 2008; Morinigo et al. 2006; Bose et al. 2010; Jorgensen et al. 2012; Salinari et al. 2013; Bojsen-Moller et al. 2014).”
BackgroundLaferrère, B., Heshka, S., Wang, K., Khan, Y., McGinty, J., Teixeira, J., Hart, A. B., & Olivan, B. (2007) · Diabetes Care · doi:10.2337/dc06-1549 · Cited by 532
Salehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323 · cited 2×
“In support of this notion, it has been shown that the incretin effect is increased in patients with type 2 diabetes after RYGB (Laferrere et al. 2007), and that blockade of the GLP-1 receptor abolishes the improved glucose homeostasis after surgery (Salehi et al. 2011; Jorgensen et al. 2013).”
BackgroundJørgensen, N. B., Jacobsen, S. H., Dirksen, C., Bojsen-Møller, K. N., Naver, L., Hvolris, L., Clausen, T. R., Wulff, B. S., Worm, D., Lindqvist Hansen, D., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2012 · Cited by 313
Cited by
Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886
“…risk factor for future development of type 2 diabetes (Lorenzo et al., 2010), and an improvement in b cell function after weight loss induced by Roux-en-Y gastric bypass surgery is an important determinant of which patients will achieve diabetes remission (Khanna et al., 2015; Lund et al., 2015).”
Effects of diet versus gastric bypass on metabolic function in diabetes
Yoshino, M., Kayser, B. D., Yoshino, J., Stein, R. I., Reeds, D., Eagon, J. C., Eckhouse, S. R., Watrous, J. D., Jain, M., Knight, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2003697 · Cited by 246
Hansen, M., Lund, M. T., Gregers, E., Kraunsøe, R., Van Hall, G., Helge, J. W., & Dela, F. (2015) · Obesity · doi:10.1002/oby.21223 · Cited by 57
Self-citationKristensen, M. D., Petersen, S. M., Møller, K. E., Lund, M. T., Hansen, M., Hansen, C. N., Courraud, J., Helge, J. W., Dela, F., & Prats, C. (2018) · Acta Physiologica · doi:10.1111/apha.13100 · Cited by 46
Self-citation
Metadata
- Authors
- Lund, M. T., Hansen, M., Skaaby, S., Dalby, S., Støckel, M., Floyd, A. K., Bech, K., Helge, J. W., Holst, J. J., & Dela, F.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2015-06-17
- Volume
- 593
- Issue
- 14
- Pages
- 3123-3133
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W1984297318
- Cited by
- 31
- References
- 10
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preoperative β‐cell function in patients with type 2 diabetes is important for the outcome of Roux‐en‐Y gastric bypass surgery. https://app.cochat.ai/papers/10.1113/jp270264
- The paper
- Lund, M. T., Hansen, M., Skaaby, S., Dalby, S., Støckel, M., Floyd, A. K., Bech, K., Helge, J. W., Holst, J. J., & Dela, F. (2015). Preoperative β‐cell function in patients with type 2 diabetes is important for the outcome of Roux‐en‐Y gastric bypass surgery. The Journal of Physiology. https://doi.org/10.1113/jp270264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.